ArticleBreast cancer research and treatment2024

The impact of erythropoiesis-stimulating agents administration concomitantly with adjuvant anti-HER2 treatments on the outcomes of patients with early breast cancer: a sub-analysis of the ALTTO study.

Diogo Martins-Branco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.